In just two years a robotic device that prints a patient’s own skin cells directly onto a burn or wound could have its first-in-human clinical trials.
The 3D bioprinting system for intraoperative skin regeneration developed by Australian biotech start-up Inventia Life Science has gained new momentum thanks to major investments from the Australian government and two powerful new partners, world-renowned burns expert Fiona Wood and leading bioprinting researcher Gordon Wallace.
Codenamed Ligō from the Latin “to bind”, the system is expected to revolutionize wound repairs by delivering multiple cell types and biomaterials rapidly and precisely, creating a new layer of skin where it has been damaged. The novel system is slated to replace current wound healing methods that simply attempt to repair the skin, and is being developed by Inventia Skin , a subsidiary of Inventia Life Science. “When we started Inventia Life Science, our vision was to […]
3D Printing News Briefs, December 3, 2020: Continuous Composites, AIMS, ULTRAWAVE, Digital Building Technologies, QOROX, Disney
In this edition of 3D Printing News Briefs, Continuous Composites has opened a new manufacturing facility, while...